Analabs
| ANALABS |
|
|
|
|
Period (Yrs) |
4 |
|
Apr-07 |
|
Apr-11 |
|
Change |
CAGR |
|
millions |
|
millions |
|
|
|
| Equity |
95.61 |
|
148.86 |
|
55.70% |
11.70% |
| LT Assets |
63.4 |
|
115.2 |
|
81.70% |
16.10% |
| Current Assets |
44.29 |
|
64.95 |
|
46.65% |
10.04% |
| LT Liabilities |
6.81 |
|
10.57 |
|
55.21% |
11.62% |
| Current Liabilities |
5.22 |
|
20.72 |
|
296.93% |
41.15% |
|
|
|
|
|
|
|
| Sales |
35.4 |
|
138.32 |
|
290.73% |
40.60% |
| Earnings |
8.36 |
|
17.67 |
|
111.36% |
20.58% |
| Interest expense |
0.04 |
|
0.27 |
|
575.00% |
61.19% |
|
|
|
|
|
|
|
| D/E |
0.00 |
|
0.00 |
|
|
|
| ROA |
7.76% |
|
9.81% |
|
|
|
| ROE |
8.74% |
|
11.87% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Market cap |
54.62 |
|
93.04 |
|
70.34% |
14.24% |
|
|
|
|
|
|
|
| P/E |
6.53 |
|
5.27 |
|
|
|
| Earnings Yield |
15.31% |
|
18.99% |
|
|
|
| P/BV |
0.57 |
|
0.63 |
|
|
|
|
|
|
|
|
|
|
| DPO ratio (historical) |
16.63% |
|
|
|
|
|
| Dividend Yield range |
High |
|
Low |
|
|
|
|
3.90% |
|
2.50% |
|
|
|
|
|
|
|
|
|
|
| Capital changes |
- |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
Sales |
|
Earnings |
|
Net Pr Marg |
Interest Exp |
| 2006 |
34.14 |
|
2.7 |
|
7.9% |
|
0.05 |
| 2007 |
35.4 |
|
8.36 |
|
23.6% |
|
0.04 |
| 2008 |
42.63 |
|
9.33 |
|
21.9% |
|
0.14 |
| 2009 |
54.65 |
|
9.19 |
|
16.8% |
|
0.23 |
| 2010 |
112.96 |
|
15.39 |
|
13.6% |
|
0.21 |
| 2011 |
138.32 |
|
17.67 |
|
12.8% |
|
0.27 |
No comments:
Post a Comment